Stay updated on Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial

Sign up to get notified when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page now returns a 403 Forbidden error, replacing the study record content with a generic error screen and site chrome. This blocks access to the study details and related sections such as Contacts and Locations.
    Difference
    18%
    Check dated 2026-09-21T22:51:45.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision v3.6.6 has been added, replacing the previous v3.6.5. This represents a minor update to the page version rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-08-31T16:21:37.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, signaling an incremental software update; no visible study content changes are indicated.
    Difference
    0.0%
    Check dated 2026-08-10T14:43:32.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page revision updated to v3.6.4, replacing the previous v3.6.3. This indicates an updated build of the study page.
    Difference
    0.0%
    Check dated 2026-07-27T06:21:32.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Explicit definitions for responder rates are added: 50%, 75%, and 100% reductions in PGTC seizures per 28-day interval during the Maintenance Phase, and a 50% reduction for all generalized seizures per 28-day interval, with Baseline and Maintenance Phase time frames and the calculation methods. These additions clarify how efficacy outcomes are measured during the Double-blind Treatment Period and Maintenance Phase.
    Difference
    0.6%
    Check dated 2026-07-20T01:46:01.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page's study locations were expanded with many new sites across multiple countries, and new results publication metadata (including posted dates and PDFs) was added; several previously listed locations and outcome-description items were removed.
    Difference
    3%
    Check dated 2026-07-05T11:24:24.000Z thumbnail image

Stay in the know with updates to Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.